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Lauren R. Darensbourg, MPH, Ivette A. López, PhD,  
Matthew T. Dutton, PhD, C. Perry Brown, DrPH 
 
ABSTRACT 
Human papillomavirus (HPV) is the most prevalent sexually transmitted disease in the United States. Prevalence rates 
among sexually active young women are approximately 50%. An HPV vaccine has been created that has high efficacy 
in preventing persistent HPV infection, cervical cancer precursor lesions, and genital warts caused by four HPV 
subtypes. The purpose of this study was to assess African-American college women’s knowledge and perceptions of 
HPV, and their association with the acceptance of HPV vaccination. Variable selection was guided by the Health 
Belief Model and the Theory of Planned Behavior. Written surveys were administered to 122 African-American women 
between the ages of 18 and 26 who were enrolled as undergraduates at Florida Agricultural and Mechanical 
University (FAMU). Statistically significant associations were found between planning to get vaccinated against HPV 
and several perception variables. Health education efforts aimed at African-American women in college should be 
renewed, given the high percentage of misconceptions about HPV among members of the study population.  
Interventions should appeal to social networks of the young women, as their opinions regarding the vaccine weighs in 
their decision to plan to get vaccinated. This study underscores the need for continuous and consistent health education 
interventions directed at African-American women of college age.  
Florida Public Health Review, 2015; 12, 34-40. 
BACKGROUND
Approximately 25 million women ages 14-59 
carry the human papillomavirus (HPV). Prevalence 
increases yearly among women starting at age 14 and 
peaks at 45% among women 20 to 24 (Dunne, 2007; 
Gonik, 2006; Slomovitz, Sun, Frumovitz, Soliman, 
Schmeler, et al. 2006). HPV is often contracted by 
adolescents and young adults shortly after the onset of 
sexual activity (Hoover, 2000). Moreover, a Centers 
for Disease Control and Prevention (CDC) study based 
on an analysis of the 2003-2004 National Health and 
Nutrition Examination Survey estimates that one in 
four (26%) young women between the ages of 14 and 
19 in the United States – or 3.2 million teenage girls – 
are infected with at least one of the most common 
sexually transmitted diseases: HPV, chlamydia, herpes 
simplex virus, and trichomoniasis (CDC, 2008). Of 
these, HPV is the most prevalent. 
HPV infection has been established as the most 
important causative factor of cervical cancer, as well as 
penile and anal cancers (Muñoz et al, 2003; Muñoz et 
al., 2000; Walboomers et al., 1999). HPV infection 
also leads to clinically apparent genital warts in 10.5% 
of all infections among women 25-34 years of age 
(Dempsey, Koutsky & Golden, 1997). Although this 
number is relatively small, genital warts can cause 
considerable morbidity and emotional stress for 
patients, as well as increased risk for cervical cancer.   
A prophylactic human papillomavirus (HPV) 
vaccine has been developed called Gardasil® 
(Markowitz et al., 2007). Clinical trials of the vaccine 
indicate that it has high efficacy in preventing 
persistent HPV infection, cervical cancer precursor 
lesions, vaginal and vulvar cancer precursor lesions, 
and genital warts caused by HPV types 6, 11, 16, or 18 
among girls and women who have not previously been 
infected with the respective HPV type (Markowitz et 
al., 2007). Knowledge among the general population 
remains sparse regarding both HPV and the HPV 
vaccine to prevent infection and future development of 
cervical cancer (Licht et al, 2010; Hopenhayn, 2007).  
Also, because HPV is sexually transmitted, cervical 
cancer also may be classified as a sexually transmitted 
infection (STI), which raises concerns of a possible 
stigma (Hopenhayn, 2007). However, one study found 
that presenting a vaccine to prevent sexually related 
problems did not seem to be a deterrent to its 
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acceptance (Boehner, 2003). In fact, the same study 
found that college students were willing to accept a 
vaccine for an STI because there are so many 
individuals that have perceived susceptibility to the 
diseases (Boehner, 2003). Consistent with the previous 
study’s findings, Hoover et al. (2000) found that girls 
and young women actually preferred a vaccine that 
targeted the STI rather than cervical cancer. Young 
women’s acceptance of the vaccine also will be 
affected by the roles of their peers, their healthcare 
coverage or the cost-effectiveness of the vaccine, as 
well as educational campaigns on HPV transmission 
and the effects of HPV infection on cervical cancer 
risk within their community (Zimet et al., 1997; Zimet 
et al., 2000). Markowitz et al. (2013) showed that the 
vaccine had reduced overall HPV prevalence among 
females aged 14-19 but did not consider racial and 
ethnic differences in vaccine acceptance.   
Previous studies in the United States show that 
knowledge of HPV is limited among adolescents, 
university undergraduates, and even women with 
abnormal Pap smears referred for further testing 
(Rosenthal et al, 2011; Licht et al, 2010; Hoover, 
2007). D’Urso, Thompson-Robinson and Chandler 
(2007) found that lack of awareness knowledge of 
HPV was high in a sample of black college students at 
a historically black university.  Yet, few studies to date 
have evaluated perceptions of the HPV vaccine among 
African-American women. The purpose of this study is 
to assess the knowledge and perceptions of HPV and 
acceptability of the HPV vaccine among African-
American college women enrolled at Florida A&M 
University, a premier historically black college/ 
university (HBCU).   
The theoretical framework that provides the 
foundation for this study is the Theory of Planned 
Behavior (TPB) (Ajzen, 1991). The TPB explores the 
relationship between behavior, attitudes and behavioral 
intentions. This theory was utilized to help determine if 
there is an association between African-American 
college women planning to get the HPV vaccine and 
their own normative, behavioral, and control beliefs.  
The knowledge variable was added to provide insight 
into whether or not an association exists between the 
modifying factors of HPV knowledge among African-
American college women and to determine if this 
association would influence their perceived threat of 
disease and intention to be vaccinated against HPV. 
 
METHODS 
We used a cross-sectional research design to 
survey African-American college women’s knowledge 
and perceptions of HPV and the HPV vaccine. The 
study was reviewed and approved by the Institutional 
Review Board of Florida A&M University (FAMU 
IRB), and a signed informed consent form was 
obtained from each study participants. 
We used a convenience sample; participants were 
recruited from 5 different classes of the journalism and 
psychology departments at FAMU. A total of 122 
eligible students participated. The entire sample was 
female, and 98% were African-American. Sample 
participants ranged in age from 18 to 25, and were 
mostly freshmen (30.3%) or seniors (34.4%) (Table 1). 
Data were derived from self-reported confidential 
surveys supplied by the 122 eligible participants. No 
overlap occurred within the study samples. 
 
Table 1. Demographic Characteristics of Study 
Participants 
 
Characteristic                     Percentage               Sample Size 
 
Gender 
 Female             100.0                           122 
Age 
 18 – 19               33.6               41 
 20 – 21               34.4               42 
 22 – 25               32.0               39 
Race 
 African American    97.5                          119 
 Mixed Race                2.5                 3 
 
Classification 
 Freshman                 30.3               37 
 Sophomore                15.6               19 
 Junior                  19.7               24 
 Senior                  34.4               42 
 
Instruments 
The survey instrument was a self-administered, 
confidential questionnaire with three sections: (1) HPV 
knowledge; (2) HPV vaccine perceptions; and (3) 
demographics. The sample was recruited from selected 
classes after permission was granted from the 
respective professors. On an agreed upon day, the 
researcher came at the beginning of class, described 
the study, and asked for volunteer participants. Women 
who volunteered to answer the self-administered 
survey completed them in the classroom, after reading 
and signing the informed consent form. The researcher 
then collected the completed surveys. 
 
HPV Knowledge Test 
A 17-item knowledge test was administered to the 
participants. This test was adapted using the Digene 
HPV Test (Digene, 2007). A knowledge variable was 
included in this study to account for any confounding 
potential, as well as to assess its significance in 
covariate and multivariate analyses. The inclusion of 
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the knowledge test is not guided by the Theory of 
Planned Behavior. 
 
HPV Vaccine Perceptions Test 
This 14-item selection of survey questions was 
guided by the Theory of Planned Behavior, and 
addresses the following theoretical constructs and 
concepts: behavioral intention (dependent variable); 
subjective norm, attitude toward behavior, normative 
beliefs, and perceived behavioral control (independent 
variables). Responses were measured using a 7-item 
Likert scale with levels of agreement ranging from 
‘Strongly Disagree’ to ‘Strongly Agree.’ Table 2 
displays the theoretical constructs in relation to the 
study variables that were established for this study. 
 
Data Analysis 
The responses to the HPV Knowledge test were 
scored (number of correct responses/total number of 
questions) for descriptive analysis to determine 
knowledge levels among students as well as for use in 
multivariate analysis. Bivariate analyses were utilized 
to determine if correlations existed between the 
dependent variable (planning to be vaccinated against 
HPV) and the independent variables derived from the 
Theory of Planned Behavior (HPV and HPV vaccine 
knowledge and perceptions). For multivariate analyses, 
responses to the HPV Perceptions Test were recoded 
into binary variables (Agree, Disagree/No Opinion). A 
multivariate logistic regression model was employed to 
determine which independent variables (subjective 
norm, normative beliefs, attitude toward the behavior, 
and perceived behavioral control) were associated with 
planning to be vaccinated against HPV (behavioral 
intent). A stepwise elimination procedure was used 
until all variables were statistically significant at α = 
.05 in the final model. All analyses were conducted 
using SPSS version 13.0 statistical software (SPSS 
Inc., Chicago, Illinois).  
 
RESULTS 
The proportion of correct answers on the HPV 
Knowledge Test ranged from 35% to 100%, with a 
mean of 74%. Of the 122 participants, 53.3% (n = 65) 
did not know that HPV was the most common STD in 
the United States.; 53.3% (n = 65) thought HPV was 
only transmitted through vaginal and anal sexual 
intercourse; moreover, 52.5% (n = 64) thought HPV 
did not affect both men and women. Bivariate and 
multivariate analyses revealed no significant 
correlations or associations between scores on the HPV  
 
 
Table 2. Theoretical Constructs and Selected Study 
Variables for Theory of Planned Behavior (TPB) 
 
Behavioral Intention  
 
o I plan to get vaccinated against HPV. 
 
 
Normative Beliefs   
 
o My family thinks I should get vaccinated against HPV. 
o My friends think I should not get vaccinated against HPV. 
o When it comes to getting vaccinated, my family’s opinion  is 
important. 






o Many people like me are vaccinated against HPV. 
o If a celebrity whose opinions I value would approve of the HPV 
vaccine, I would be more likely to get vaccinated. 
o I would be more likely to be vaccinated if influential  women 
whose  opinions I value would approve of my vaccination. 
 
 
Attitude toward the Behavior 
 
o Vaccination is bad. 
o Vaccination is valuable. 
 
 
Perceived Behavioral Control 
 
o If I wanted to, I could get vaccinated against HPV. 
o It is mostly up to me whether or not I get vaccinated against HPV. 
 
 
Modifying Factor (cognitive measure external to TPB) 
 




knowledge test and planning to be vaccinated against 
HPV in this population.   
Statistically significant correlations were found at 
α = .05 level between planning to be vaccinated against 
HPV and: agreeing that ‘Vaccination is valuable,’ 
agreeing that ‘I could get vaccinated if I wanted to,’ 
disagreeing that ‘My family thinks I should get 
vaccinated against HPV,’ disagreeing that ‘Most 
people important to me think I should not be 
vaccinated against HPV,’ and disagreeing that ‘I would 
be more likely to get vaccinated if influential women 
whose opinions I value would approve of my 
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Table 3. Bivariate Results: HPV Perceptions Associated 










o Vaccination is bad. 
 
      .083       .365 
o Vaccination is valuable. 
 
      .539*    <.001 
o I could get vaccinated if  
I wanted to. 
 
      .287*                  .001 
o My family thinks I should   
be vaccinated. 
 
      .252*                  .005 
o Important people think I 
should not get vaccinated. 
             
      .269*                   .003 
o More likely to get 
vaccinated if valued  
influential women would  
approve of vaccination. 
      .528*           
  
   <.001 
            
   
*Indicates the correlation is significant at the .05 level (2-tailed). 
 







    Freshman (Reference group) 
    Sophomore 
    Junior 














Vaccination is valuable. 
    No Opinion or Disagree (Reference 
group) 









My family thinks I should get 
vaccinated. 













If influential women whose opinions 
I valued approved of my vaccination, 
I would be more likely to get 
vaccinated. 

















*Indicates the association is significant at the 0.05 level (2-tailed). 
 
In the multivariate model for HPV perceptions 
(i.e., intent to be vaccinated against HPV), there were 
no significant associations between HPV knowledge 
and planning to be vaccinated in this population. 
However, after stepwise elimination, variables 
measuring attitude toward planning to get vaccinated 
for HPV, normative beliefs, and social norms related to 
the HPV vaccine were found to be significantly 
associated with planning to get vaccinated against 
HPV in this population. Table 4 displays the odds 
ratios (OR) and p-values of the significant predictors.  
The following factors were found to be significantly 
associated: being a college Junior increased the 
likelihood of vaccination relative to being a Freshman; 
those who agreed ‘Vaccination is valuable’ were over 
5 times more likely to plan to be vaccinated than those 
who disagreed/had no opinion; those who agreed ‘My 
family thinks I should get vaccinated against HPV’ 
were almost 11 times more likely to plan to be 
vaccinated than those who disagree/had no opinion; 
those who agreed ‘I would be more likely to get 
vaccinated against HPV if influential women whose 
opinions I valued approved of my vaccination’ were 
6.5 times more likely to plan to be vaccinated than 
those who did not agree; all other variables were not 
significant at the α = .05 level. 
 
DISCUSSION 
In this study, we examined African American 
college women’s level of HPV knowledge and 
perceptions of HPV and the HPV vaccine in 
association to planning to be vaccinated against HPV.  
Although HPV knowledge was not found to be 
significantly correlated or associated with planning to 
be vaccinated against HPV in this population, 
constructs of the Theory of Planned Behavior such as, 
attitude toward the behavior, subjective norms, and 
normative beliefs were found to influence planning to 
be vaccinated against HPV.  Further, there was an 
overall high intent to be vaccinated against HPV in this 
population (68%).  This study has the potential to 
become important to the development and 
implementation of public health strategies and 
interventions to increase awareness and education of 
HPV and the HPV vaccine among African American 
young women on college campuses across the nation.   
The finding of low knowledge levels among 
participating women is not dissimilar from other study 
results.  D’Urso and colleagues (2007) found that black 
students at one HBCU were as misinformed about 
HPV as their white counterparts.  The study 
participants reported alarming misconceptions, 
although different knowledge tests were utilized 
(D’Urso et al, 2007).  Clearly, there is an urgent need 
to address the lack of accurate HPV information 
created for this population segment.  
Despite the level of misinformation, most of the 
participants had a positive outlook regarding the HPV 
vaccine. Whereas this is a mostly constructive finding, 
the HPV vaccination decision should optimally be 
taking place at an earlier age (ideally 9-13 years of age, 
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but any time after that until the age of 26), in order to 
benefit fully from the vaccines protection.   Therefore, 
the benefit of the vaccine is limited due to risky sexual 
activity that a young woman may have participated in 
by the time she attends college.   Some of the negative 
associations between being a junior college student 
(presumably older) and the behavioral intent of getting 
the HPV vaccine may be related to the women’s 
perception that it may be too late for them.      
Regarding the multivariate model for HPV 
perceptions (i.e. intent to be vaccinated against HPV), 
the following factors were found to be significantly 
associated: being a college Junior, agreeing 
‘Vaccination is valuable,’ agreeing ‘My family thinks I 
should get vaccinated against HPV,’ and agreeing ‘I 
would be more likely to get vaccinated against HPV if 
influential women whose opinions I valued approved 
of my vaccination.’  Regarding the association of 
intent to vaccinate and agreeing the “vaccination is 
valuable” and “my family thinks I should get 
vaccinated against HPV,” these are areas where health 
education interventions tailored for African American 
young women should center. The importance of 
familial support for vaccination is supported by much 
of the literature despite barriers to vaccine acceptance 
among many parents (Keane et al, 2005; Taylor et al, 
2002; Diekema, 2005, Davis et al, 2004).  
Furthermore, positive perceptions of the vaccine 
(‘vaccination is valuable’) were expressed by a 
majority of the study participants.  Yet since these 
perceptions showed a significant association with 
vaccination intent, they should be an area of focus for 
health education interventions.  Finally, the last 
significant associations were found between intent to 
vaccinate and agreement with ‘I would be more likely 
to get vaccinated against HPV if influential women 
whose opinions I valued approved of my vaccination.’  
The study participants express openness toward a 
female role model regarding the vaccination. The 
opinions of influential others are clearly associated 
with the intention of becoming vaccinated against 
HPV.  A physician’s recommendation may have also 
swayed some women, as stated by Rosenthal et al 
(2011), but this was not measured in the present study.  
Health educators and service providers should 
incorporate the social influence of family members, 
friends, peers and role models.  
  
Conclusion 
In conclusion, HPV interventions should be 
developed taking into consideration the opinions of the 
social networks in the lives of African American 
college women.  Emphasis should be placed on 
comprehensive sexual education given the high 
misconceptions about HPV within this population, and 
should focus on education, awareness and prevention 
of HPV, cervical cancer, and genital warts.  
Furthermore, public health initiatives should be 
tailored to account for the differences in perceptions 
between different college classifications. 
Limitations for this study may have included 
instrument bias, as reliability of the tests were not 
obtained.  The small sample size may have impeded 
the detection of existing correlations.   Future studies 
on HPV should explore the knowledge and perceptions 
of males because knowing which factors influence 
their intention to be vaccinated against HPV will be 
important in the effective development of audience 
appropriate HPV awareness and prevention 
interventions.  A larger study sample should be 
recruited to make the data set more generalizable to the 
national population and to support the data analyses to 
be run.  Moreover, future studies should explore the 
possibility of an association between intent to get 
vaccinated against HPV and perceived threat and 
severity of HPV (Health Belief Model), as well as 
control and behavioral beliefs related to intent to be 
vaccinated against HPV (Theory of Planned Behavior).  
Additionally, a factor analysis should be performed on 
the HPV knowledge test to develop a knowledge scale 
to further explore if an association exists between HPV 
knowledge and intent to be vaccinated against HPV. 
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